Plain-English translation of NCT04703699 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a study that looks back at the medical records of about 200 patients who have already received the Myval transcatheter heart valve to treat severe aortic valve stenosis (a narrowing of the heart valve). Researchers want to understand how safe and effective this treatment is when used in everyday medical practice, not just in controlled research settings. The study will track patients for 30 days after their procedure to see how well they recover.
Aortic valve stenosis can be life-threatening, and while traditional surgery works for some patients, not everyone can have open-heart surgery. This medication offers a less invasive option, but researchers need real-world data to confirm it's safe and works well across different patient groups and hospitals worldwide.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will review your existing medical records from your heart valve procedure and your 30-day recovery period — you won't need to have additional procedures or office visits. They will collect information about how you're doing, any complications you may have experienced, and how well your new valve is working. This is a retrospective study, meaning it only uses information that has already been collected as part of your normal care.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Estonia
Italy
Netherlands
Poland
Slovenia